(Total Views: 355)
Posted On: 10/19/2020 9:04:47 PM
Post# of 36566
GMIN,
The populous in China has basically been sheltering in place since March. Regardless of the numbers China needs a go-to Vaccine. In China, everyone will be vaccinated. Just off of this partnership alone NGIO will become a billion dollar company annually. Even though the Govt provides it, the vaccine will still have a cost into the health system, so there's alot to gain. I do agree that they should do all they can to front load the contract and ratchet the share of revenue to be large upfront and less over time to mitigate potential business issues. Having a partner such as the suggested company in China (Chinese Pfizer Equivalent) is a feather in NGIO's cap.
The populous in China has basically been sheltering in place since March. Regardless of the numbers China needs a go-to Vaccine. In China, everyone will be vaccinated. Just off of this partnership alone NGIO will become a billion dollar company annually. Even though the Govt provides it, the vaccine will still have a cost into the health system, so there's alot to gain. I do agree that they should do all they can to front load the contract and ratchet the share of revenue to be large upfront and less over time to mitigate potential business issues. Having a partner such as the suggested company in China (Chinese Pfizer Equivalent) is a feather in NGIO's cap.
(2)
(0)
